Ductal prostate cancer

被引：0
|
作者：
Biryukov, V. A. [1 ]
Gorban, N. A. [2 ]
Karyakin, O. B. [1 ]
Neledov, D. V. [1 ]
Kaprin, A. D. [1 ]
机构：
[1] Minist Hlth Russia, Natl Med Radiol Res Ctr, AF Tsyb Med Radiol Res Ctr, 10 Zhukov St, Obninsk 249036, Kaluga Region, Russia
[2] Russian Def Minist, Main Mil Clin Hosp, 3 Hosp Sq, Moscow 105229, Russia
来源：
ONKOUROLOGIYA | 2016年 / 12卷 / 01期
关键词：
prostate cancer; ductal prostate adenocarcinoma; docetaxel;
D O I：
10.17650/1726-9776-2016-12-1-74-80
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Prostate cancer (PC) preserves its leading position among male tumors. Ductal carcinoma is the second common type of prostate adenocarcinoma. The paper describes different types of ductal carcinoma, which have their morphological pattern. Ductal adenocarcinoma is a relatively rare morphological type of prostate adenocarcinoma traditionally regarded as a more aggressive type of PC, which is represented by the common forms with high Gleason scores (9, 10) and no well-defined treatment regimen. This paper describes 3 cases of ductal PC diagnosed at our center.
引用
收藏
页码：74 / 80
页数：7
相关论文
共 50 条
  • [1] THE SPECIFIC CLINICAL CHARACTERISTICS OF DUCTAL PROSTATE CANCER
    Leibovici, D.
    Tu, S. M.
    Lopez, A.
    Pagliaro, L. C.
    Kuban, D. A.
    Logothetis, C. J.
    Pisters, L. L.
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) : 277 - 277
  • [2] Optimizing the diagnosis and management of ductal prostate cancer
    Ranasinghe, Weranja
    Shapiro, Daniel D.
    Zhang, Miao
    Bathala, Tharakeswara
    Navone, Nora
    Thompson, Timothy C.
    Broom, Bradley
    Aparicio, Ana
    Tu, Shi-Ming
    Tang, Chad
    Davis, John W.
    Pisters, Louis
    Chapin, Brian F.
    NATURE REVIEWS UROLOGY, 2021, 18 (06) : 337 - 358
  • [3] Optimizing the diagnosis and management of ductal prostate cancer
    Weranja Ranasinghe
    Daniel D. Shapiro
    Miao Zhang
    Tharakeswara Bathala
    Nora Navone
    Timothy C. Thompson
    Bradley Broom
    Ana Aparicio
    Shi-Ming Tu
    Chad Tang
    John W. Davis
    Louis Pisters
    Brian F. Chapin
    Nature Reviews Urology, 2021, 18 : 337 - 358
  • [4] Immunohistochemical verification of ductal differentiation in prostate cancer
    Tarjan, Miklos
    Lenngren, Anna
    Hellberg, Dan
    Tot, Tibor
    APMIS, 2012, 120 (06) : 510 - 518
  • [5] Ductal prostate cancer: Contemporary management and outcomes
    Orihuela, Eduardo
    Green, Justin M.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2008, 26 (04) : 368 - 371
  • [6] Macrocystic ductal adenocarcinoma of prostate: A rare gross appearance of prostate cancer
    Kojima, Fumiyoshi
    Koike, Hiroyuki
    Matsuzaki, Ibu
    Iwahashi, Yoshifumi
    Warigaya, Kenji
    Fujimoto, Masakazu
    Ono, Kazuo
    Urata, Youji
    Kohjimoto, Yasuo
    Hara, Isao
    Murata, Shin-ichi
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2017, 27 : 7 - 13
  • [7] Cystic prostate cancer: a clinical entity of ductal carcinoma
    Zini, L
    Villers, A
    Leroy, X
    Ballereau, C
    Lemaitre, L
    Biserte, J
    PROGRES EN UROLOGIE, 2004, 14 (03): : 411 - 413
  • [8] Isolated recurrence of ductal prostate cancer to anterior urethra
    Green, Justin M.
    Tang, Wendell W.
    Jensen, Burkitt W.
    Orihuela, Eduardo
    UROLOGY, 2006, 68 (02) : 428.e13 - 428.e15
  • [9] A review of the incidence, management and prognosis of the ductal subtype of prostate cancer
    Mathur, N.
    Beckmann, K.
    Moretti, K.
    Kopsaftis, T.
    D'Onise, K.
    Walsh, S.
    O'Callaghan, M.
    BJU INTERNATIONAL, 2016, 117 : 97 - 98
  • [10] Mri and psma in the primary staging of ductal variant prostate cancer
    Patel, N.
    Franklin, A.
    Yaxley, J.
    Hemamali, S.
    Roberts, M. J.
    EUROPEAN UROLOGY, 2023, 83
12345